Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Dr Ross Laybutt

 

Senior Research Officer; Group Leader, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; Conjoint Senior Lecturer, The University of New South Wales

Email: r.laybutt 'at' garvan.org.au
Research Group: Laybutt

 
 

Education

1994 BSc (Hons) Class 1, The University of New South Wales
1998 PhD, The University of New South Wales

Awards and Honours (NEED DATES)

Juvenile Diabetes Foundation Post-Doctoral Fellowship
RD Wright Biomedical Career Development Award (NHMRC)
NHMRC Early Career Researcher Award, Australian Academy of Science

Publications

Laybutt DR, Hawkins YC, Lock J, Lebet J, Sharma A, Bonner-Weir S, Weir GC. Influence of diabetes on the loss of beta cell differentiation after islet transplantation. Diabetologia 2007; 50:2117-2125

Schmitz-Peiffer C, Laybutt DR, Burchfield JG, Gurisik E, Narasimhan S, Mitchell CJ, Pedersen DJ, Braun U, Cooney GJ, Leitges M, Biden TJ. Inhibition of PKC epsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 2007; 6:320-328

Laybutt DR, Preston AM, Åkerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ. Endoplasmic reticulum stress contributes to β-cell apoptosis in type 2 diabetes. Diabetologia 2007; 50: 752-763

Kjørholt C, Åkerfeldt MC, Biden TJ, Laybutt DR. Chronic Hyperglycemia, Independent of Plasma Lipid Levels, Is Sufficient for the Loss of {beta}-Cell Differentiation and Secretory Function in the db/db Mouse Model of Diabetes. Diabetes 2005; 54(9):2755-63.

Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S, Weir GC. Critical reduction in β-cell mass results in two distinct outcomes over time. J Biol Chem 2003; 278:2997-3005.

Laybutt DR, Kaneto H, Hasenkamp W, Grey S, Jonas J-C, Groff A, Ferran F, Bonner-Weir S, Sharma A, Weir GC. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes 2002; 51:413-423

Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC. Genetic regulation of metabolic pathways in β-cells disrupted by hyperglycemia. J Biol Chem 2002; 277:10912-21

Laybutt DR, Weir GC, Kaneto H, Lebet J, Palmiter RD, Sharma A, Bonner-Weir S. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression and diabetes. Diabetes 2002; 51:1793-1804

Jonas JC, Laybutt DR, Steil GM, Trivedi N, Pertusa JG, de Casteele MV, Weir GC, Henquin JC. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta-cells. J Biol Chem 2001; 276:35375-35381

Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders T, Bonner-Weir S, Kaufman RJ. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 2001; 7:1165-1176


Search for all publications by Laybutt

 
 
 

Areas of Interest

islet cells, apoptosis, hyperglycaemia, hyperlipidaemia, islet biology, ER stress, endoplasmic reticulum stress,
 

News

 

Potential to prevent loss of insulin in Type 2 diabetes

MEDIA RELEASE: 14 Jul 2008
Until now, it was thought that the processes leading to the death of insulin-secreting pancreatic cells were similar in both types of diabetes. Scientists at Garvan have now shown that the process is quite different in the two diseases. They have also identified a promising therapeutic target for people with Type 2 diabetes
 
 

Personal tools